Cargando…
Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Non-small cell lung cancer (NSCLC) is a prevalent and lethal disease. Circulating cell-free miRNA has the potential to serve as a biomarker for early detection as it reflects cancer characteristics. Through global miRNA profiling in serum samples from NSCLC patients and non-cancerous...
Autores principales: | Charkiewicz, Radoslaw, Sulewska, Anetta, Mroz, Robert, Charkiewicz, Alicja, Naumnik, Wojciech, Kraska, Marcin, Gyenesei, Attila, Galik, Bence, Junttila, Sini, Miskiewicz, Borys, Stec, Rafal, Karabowicz, Piotr, Zawada, Magdalena, Miltyk, Wojciech, Niklinski, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605272/ https://www.ncbi.nlm.nih.gov/pubmed/37894277 http://dx.doi.org/10.3390/cancers15204910 |
Ejemplares similares
-
miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping
por: Charkiewicz, Radoslaw, et al.
Publicado: (2023) -
Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()
por: Charkiewicz, Radoslaw, et al.
Publicado: (2017) -
miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives
por: Dobrzycka, Margarita, et al.
Publicado: (2023) -
A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
por: Sulewska, Anetta, et al.
Publicado: (2023) -
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
por: Michalska-Falkowska, Anna, et al.
Publicado: (2023)